The call is that falling long rates are repricing everything outside tech right now rather than earnings, and Cramer says growth stocks away from semis are the clean way to play it. He is warning ...
Phase 1 clinical trial to evaluate local intravesical administration of UGN-501 UGN-501 is a differentiated investigational next-generation oncolytic virus designed to combine direct tumor cell ...
Ractigen Therapeutics, a leading clinical-stage biopharmaceutical company developing innovative small activating RNA (saRNA) ...
Experts identify five invasive plants spreading in the Southeast and share how to spot them before they crowd out native ...
Two major international studies have provided the strongest evidence to date supporting the accuracy of non-invasive tests in ...
It may sound abstract, but distinctions between "native," "introduced" or "invasive" species can often be life or death.
This is a record of my breast cancer experience. Since treatments and symptoms vary from person to person, please read this ...
Swiss startup Liom is developing a wrist-worn wearable that uses Raman spectroscopy and miniaturized photonics to monitor ...
Reporter Emily Brindley's piece lays out three takeaways from the project, including a ride-along account of a surgical team ...
"While the negative results are encouraging, they do not definitively rule out the presence of invasive mussels in the lake," ...
Doctors at Montefiore Einstein Comprehensive Cancer Center are conducting an active surveillance study where certain breast ...
Two major international studies have delivered the strongest evidence to date on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results